Rebecca Goydel, Ph.D.
Doctoral Thesis: Broadening the Target Range of T-cell Engaging Bispecific Antibodies
Description of Research Focus: Goydel’s research focused on developing a conditionally active antibody format which makes traditionally unsafe targets safe to use as cancer targets, broadening the treatable cancers with a single therapy.
Undergraduate Institution: Fairmont State University
Noteworthy Publications: Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications, Journal of Biological Chemistry (2020); Antibody-based cancer therapy, Oncogene (2021)
Honors & Awards: Frenchman's Creek Women for Cancer Research Fellowship (2018-2020); Klorfine Foundation Fellowship (2017-2018)
Looking Back: "When I look back on my graduate school time at The Scripps Research Institute I smile and think of all the great memories. This is mostly due to my PhD advisor, Dr. Christoph Rader and my fellow labmates. The amount of daily support, laughs, and encouragement made it a truly positive experience along with thoroughly preparing me to transition into industry."
Next Steps: "I currently work at Seismic Therapeutic in Cambridge, MA as a scientist and team-lead in the Antibody Discovery group. As the 6th employee (second in the lab), I have been able to help the company grow as I also grow and learn all the different aspects of what makes a successful biotech company. I hope to utilize this knowledge in the future as I continue to progress in biotech and eventually consult or have a more people-facing science-driven position."
Be sure to join us at 10 a.m. PDT on Friday, May 20 for our Commencement Ceremony Livestream! Goydel's advisor and mentor, Prof. Christoph Rader, will deliver a few words about her graduate experience, and viewers can learn about our 47 other 2022 graduates, who are now setting out to build careers that will profoundly impact the future of biomedical research.
